Loading…
Specialized medicine - private practice in საბურთალოს რაიონი, ქ. თბილისი. Address: საქართველო, თბილისი, საბურთალოს რაიონი, ს. ცინცაძის ქ., N23.
GCAP internal — Sectors and enrichment.xlsx (2026-06-10)
| Ratio | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 82.2% | 77.9% | 82.2% | 80.0% | 60.8% |
| EBITDA Margin | 5.2% | 11.6% | 27.6% | 27.6% | 23.2% |
| EBITDAR | 287 | 540 | 1,432 | 978 | 1,105 |
| EBITDAR Margin | 7.7% | 14.1% | 27.6% | 27.8% | 23.2% |
| EBIT Margin | 2.2% | 9.3% | 25.4% | 25.2% | 17.5% |
| Net Profit Margin | 5.2% | 7.8% | 24.7% | 25.2% | 17.5% |
| Operating Expense % of Sales | 77.0% | 66.3% | 54.6% | 52.4% | 37.6% |
| Returns | |||||
| Return on Assets (ROA) | 9.4% | 11.0% | 28.7% | 17.9% | 16.2% |
| Return on Equity (ROE) | 23.1% | 26.2% | 53.1% | 26.8% | 20.2% |
| ROIC [EBIT / Invested Capital] | 10.0% | 28.2% | 72.8% | 51.7% | 23.0% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 32.7% | 22.7% | 14.8% | 7.5% | 12.4% |
| Debt-to-Equity | 0.81x | 0.54x | 0.27x | 0.11x | 0.15x |
| Debt-to-EBITDA | 3.49x | 1.37x | 0.46x | 0.38x | 0.58x |
| Equity-to-Assets | 40.6% | 42.2% | 54.1% | 66.7% | 80.5% |
| Net Debt | -17 | 123 | -600 | -1,588 | -503 |
| Cash & Equivalents | 690 | 487 | 1,262 | 1,956 | 1,141 |
| Total Debt | 674 | 610 | 661 | 369 | 638 |
| Liquidity & working capital | |||||
| Current Ratio | 0.56x | 0.36x | 0.00x | 0.00x | 0.00x |
| Quick Ratio | 0.56x | 0.36x | -0.05x | -0.17x | -0.00x |
| Cash Ratio | 0.55x | 0.32x | 0.61x | 1.19x | 1.14x |
| Total Current Assets | 704 | 547 | 0 | 0 | 0 |
| Total Current Liabilities | 1,261 | 1,531 | 2,051 | 1,646 | 1,003 |
| Inventory | N/A | N/A | 109 | 274 | 5 |
| Trade Receivables | 14 | 61 | 202 | N/A | 774 |
| Trade Payables | 587 | 921 | 1,390 | 1,278 | 365 |
| Net Working Capital | -557 | -983 | -2,051 | -1,646 | -1,003 |
| Net Working Capital % of Revenue | -15.0% | -25.7% | -39.5% | -46.8% | -21.0% |
| Trade Working Capital | -574 | -860 | -1,079 | -1,003 | 414 |
| Trade Working Capital % of Revenue | -15.4% | -22.5% | -20.8% | -28.5% | 8.7% |
| Change in Trade Working Capital | N/A | -287 | -219 | 76 | 1,417 |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | N/A | 8.51x | 2.57x | 400.60x |
| Days Inventory Outstanding (DIO) | N/A | N/A | 42.9 | 142.0 | 0.9 |
| Receivables Turnover | 273.62x | 62.81x | 25.70x | N/A | 6.16x |
| Days Sales Outstanding (DSO) | 1.3 | 5.8 | 14.2 | N/A | 59.2 |
| Payables Turnover | 1.12x | 0.92x | 0.66x | 0.55x | 5.13x |
| Days Payable Outstanding (DPO) | 324.8 | 397.9 | 549.0 | 661.7 | 71.2 |
| Cash Conversion Cycle | -323.4 days | -392.1 days | -491.9 days | -519.7 days | -11.0 days |
| Asset Turnover | 1.80x | 1.42x | 1.16x | 0.71x | 0.93x |
| Cash flow & dividends | |||||
| Operating Cash Flow | 119 | -204 | 775 | 695 | -815 |
| Free Cash Flow (OCF − Capex proxy) | 119 | -204 | 775 | 695 | -815 |
| Cash Conversion (OCF / EBITDA) | 61.6% | -45.9% | 54.1% | 71.7% | -73.8% |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →